V010-6277 Screening compound: N-[2-(benzylsulfanyl)ethyl]-4-{3-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}benzamide

V010-6277 Screening compound: N-[2-(benzylsulfanyl)ethyl]-4-{3-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}benzamide
V010-6277 Screening compound: N-[2-(benzylsulfanyl)ethyl]-4-{3-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V010-6277
N-[2-(benzylsulfanyl)ethyl]-4-{3-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V010-6277

Molecular Formula

C26H22F3N3OS (C26 H22 F3 N3 OS)

Compound Name

N-[2-(benzylsulfanyl)ethyl]-4-{3-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}benzamide

IUPAC name

N-[2-(benzylsulfanyl)ethyl]-4-{3-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}benzamide

SMILES

O=C(c(cc1)ccc1-c1cc(-c2cc(C(F)(F)F)ccc2)n[nH]1)NCCSCc1ccccc1

InChI

InChI=1S/C26H22F3N3OS/c27-26(28,29)22-8-4-7-21(15-22)24-16-23(31-32-24)19-9-11-20(12-10-19)25(33)30-13-14-34-17-18-5-2-1-3-6-18/h1-12,15-16H,13-14,17H2,(H,30,33)(H,31,32)

InChI Key

PVNAFZBSGJJXCZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19953954

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

481.54

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.063

Distribution Coefficient, logD

6.063

Water Solubility, LogSw

-6.31

Polar Surface Area

46.711

Acid Dissociation Constant (pKa)

8.35

Base Dissociation Constant (pKb)

-0.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.40

V010-6277 in Drug Discovery

Included in Screening Libraries

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V010-6277 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V010-6277?
Check Price and Availability of V010-6277, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V010-6277 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V010-6277
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V010-6277
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V010-6277 available by request